|
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 2.016,00 DKK | +1,23% |
|
-2,33% | +34,94% |
| 09/12 | BillionToOne boekt winst in derde kwartaal, omzet stijgt; aandeel daalt na beurs | MT |
| 09/12 | Bemoedigende vroege resultaten voor epcoritamab bij patiënten met Richter-transformatie | RE |
Belangrijkste concurrenten
Toevoegen aan een lijst 0 geselecteerde | Verschil (%) | Varia. 5d. | Evolutie 1 maand | Evolutie 3 maanden | Var. 1 jan | Varia. 1j. | Varia. 3j. | Varia. 5j. | Varia. 10j. | Kap.($) | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1,23% | -2,33% | +4,95% | +10,57% | +34,94% | +31,12% | -38,05% | -16,05% | +121,08% | 19,13 mld. | |
| -1,53% | -4,27% | -0,55% | +15,82% | +26,40% | +30,71% | +100,11% | +210,82% | +7.678,46% | 54,9 mld. | |
| -2,22% | -8,19% | -1,08% | +30,10% | +174,99% | +161,43% | +928,44% | +377,25% | +983,62% | 40,49 mld. | |
| +0,63% | +5,85% | -0,75% | -13,50% | +68,51% | +60,00% | +15,94% | +1,50% | - | 39,05 mld. | |
| -0,12% | -1,03% | -8,88% | -5,21% | -15,99% | -18,07% | -43,78% | -26,10% | - | 23,02 mld. | |
| -0,30% | +1,64% | +0,72% | -7,00% | +90,66% | +81,76% | -35,43% | -58,92% | - | 17,81 mld. | |
| +0,51% | -4,86% | +2,62% | -8,07% | +93,41% | +85,61% | +192,40% | +307,64% | - | 13,83 mld. | |
| +5,41% | -2,34% | -1,97% | +1,90% | +0,53% | -0,17% | +357,65% | +270,66% | +64,14% | 13,83 mld. | |
| +1,31% | -6,99% | +1,16% | -14,98% | +155,73% | +120,02% | - | - | - | 12,35 mld. | |
| -0,26% | -4,73% | +11,41% | +28,45% | +79,04% | +76,64% | +725,69% | +358,71% | - | 12,55 mld. | |
| -1,91% | -6,68% | -0,82% | +8,94% | +23,33% | +16,58% | +160,43% | +112,25% | +718,13% | 11,06 mld. | |
| -1,74% | +2,91% | - | - | - | - | - | - | - | 9,56 mld. | |
| +0,06% | +5,83% | +72,82% | +138,39% | +266,33% | +187,92% | +127,74% | -6,94% | +1.079,28% | 9,35 mld. | |
| -4,88% | -18,74% | -26,19% | +45,17% | - | - | - | - | - | 8,46 mld. | |
| +0,74% | -.--% | -.--% | -.--% | -.--% | -.--% | +72,26% | +169,06% | - | 8,19 mld. | |
| +0,62% | -1,09% | +13,72% | +34,70% | +35,08% | +13,75% | +240,99% | - | - | 8,21 mld. | |
| -2,09% | -6,72% | -3,03% | +15,99% | +28,22% | +19,32% | +68,62% | +203,40% | +419,51% | 7,37 mld. | |
| -0,35% | -.--% | -0,52% | +93,15% | - | - | - | - | - | 7,43 mld. | |
| +0,43% | +0,68% | +1,41% | +44,15% | +130,13% | +125,36% | +623,78% | +450,46% | - | 7,34 mld. | |
| +9,02% | +1,00% | +101,99% | +97,28% | +578,93% | +585,81% | +723,53% | +601,21% | - | 7,61 mld. | |
| Gemiddelde | +0,28% | -1,70% | +8,79% | +27,15% | +104,13% | +92,81% | +263,77% | +197,00% | +1.580,60% | 16,58 mld. | |
| Gewogen gemiddelde per kap. | -0,09% | -1,86% | +4,01% | +17,20% | +84,76% | +76,45% | +252,56% | +172,98% | +3.110,74% |
- Beurs
- Aandelen
- Koers GMAB
- Sector Genmab A/S
Kies jouw editie
Alle financiële informatie op nationaal niveau
